WHO monographs on selected medicinal plants - travolekar.ru
WHO monographs on selected medicinal plants - travolekar.ru
WHO monographs on selected medicinal plants - travolekar.ru
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
F<strong>ru</strong>ctus Myrtilli<br />
Major chemical c<strong>on</strong>stituents<br />
Besides the normal organic acids (3–7%; e.g. citric acid and malic acid),<br />
phenolic acids and other phenols, the f<strong>ru</strong>its c<strong>on</strong>tain up to 10% tannins<br />
(mostly catechol tannins). The major characteristic and biologically<br />
active c<strong>on</strong>stituents are flav<strong>on</strong>oids and anthocyanins. Examples of flav<strong>on</strong>ol-O-glycosides<br />
in fresh bilberry juice and f<strong>ru</strong>it include quercetin-3-rhamnoside<br />
(quercitrin), quercetin-3-glucoside (isoquercitrin),<br />
quercetin-3-galactoside (hyperoside), and kaempferol-3-glucoside<br />
(astragalin). More than 15 anthocyanins (totalling approximately<br />
0.5%) have been identified as 3-arabinosides, 3-glucosides and 3-galactosides<br />
of five anthocyanidins: cyanidin, delphinidin, malvidin,<br />
pe<strong>on</strong>idin and petunidin, with cyanidin and delphinidin glycosides<br />
accounting for 64% of the total anthocyanins (2, 3, 5, 10). St<strong>ru</strong>ctures<br />
of the 3-glucosides of cyanidin, delphinidin, malvidin, pe<strong>on</strong>idin and<br />
petunidin are presented below.<br />
HO<br />
OH<br />
Cl - 3<br />
O +<br />
O<br />
Glc<br />
R1<br />
OH<br />
R2<br />
Cyanidin<br />
Delphinidin<br />
Malvidin<br />
Pe<strong>on</strong>idin<br />
Petunidin<br />
R1 = OH R2 = H<br />
R1 = R2 = OH<br />
R1 = R2 = OCH 3<br />
R1 = OCH 3 R2 = H<br />
R1 = OH R2 = OCH 3<br />
3-m<strong>on</strong>oglucosides<br />
HO<br />
O<br />
Glc = OH<br />
HO<br />
OH<br />
-D-glucopyranosyl<br />
Medicinal uses<br />
Uses supported by clinical data<br />
Oral use for the symptomatic treatment of dysmenorrhoea associated<br />
with premenst<strong>ru</strong>al syndrome (11), circulatory disorders in patients with<br />
capillary leakage or peripheral vascular insufficiency (12–16) and ophthalmic<br />
disorders (17–19).<br />
Uses described in pharmacopoeias and well established documents<br />
Oral use for the treatment of acute diarrhoea and local irritati<strong>on</strong> or inflammati<strong>on</strong><br />
of the mucous membranes of the mouth and throat (20).<br />
Uses described in traditi<strong>on</strong>al medicine<br />
Treatment of capillary fragility, diarrhoea, eye disorders, haemorrhoids,<br />
intestinal disorders, skin disorders and venous insufficiency. Also used as<br />
a diuretic (2, 3).<br />
213